Bank of Montreal
VERV

Bank of Montreal’s Verve Therapeutics VERV Stock Holding History

Bank of Montreal’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,456
Closed -$174K – 3818
2025
Q2 		$174K Sell
15,456
-14,859
-49% -$84.7K ﹤0.01% 2857
2025
Q1 		$139K Sell
30,315
-13,824
-31% -$92.6K ﹤0.01% 2839
2024
Q4 		$249K Sell
44,139
-6,131
-12% -$34.6K ﹤0.01% 2647
2024
Q3 		$250K Sell
50,270
-2,071
-4% -$12K ﹤0.01% 2895
2024
Q2 		$275K Sell
52,341
-2,437
-4% -$15.3K ﹤0.01% 2792
2024
Q1 		$735K Sell
54,778
-38,612
-41% -$512K ﹤0.01% 2185
2023
Q4 		$1.4M Buy
93,390
+20,862
+29% +$259K ﹤0.01% 1875
2023
Q3 		$1.04M Buy
+72,528
New +$1.17M ﹤0.01% 2045
2023
Q2 		– Sell
-23,252
Closed -$357K – 4318
2023
Q1 		$357K Buy
+23,252
New +$455K ﹤0.01% 2671

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of Montreal's VERV Position: Q3 2025 in Review

Bank of Montreal sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 15,456 shares — an estimated $174K sold.

Bank of Montreal first reported a position in VERV in Q1 2023 and held it in 9 quarters. The position peaked at $1.4M in Q4 2023. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Bank of Montreal reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 15,456 Verve Therapeutics shares in Q3 2025, an estimated $174K.
  • Bank of Montreal first reported a position in Verve Therapeutics in Q1 2023 and held it in 9 quarters.
  • Bank of Montreal's Verve Therapeutics position peaked at $1.4M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.